Physician

Raymond Wee, MD

According to 2025 Medicare claims, Raymond Wee, MD (NPI: 1104980382) practices ophthalmology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF HAWAII INC (NPI: 1124089446; TIN: 990300258) and primary practice location at 96701-4723.

Wee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 975 traditional Medicare patients, billed 28,489 HCPCS/CPT codes, and received $1,565,930 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 357 prescription claims across 145 beneficiaries totaling $50,713 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 18 records totaling $22,386. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $29,753 to $50,713. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$847K$1.7M2015 Medicare payment: $1,099,038 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,482,551 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,611,082 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,677,379 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,416,043 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,389,920 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,694,659 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,532,564 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,564,041 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,565,930 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157776,794$1,099,038
20168987,928$1,482,551
20179338,216$1,611,082
20181,0158,842$1,677,379
20199847,495$1,416,043
20208696,826$1,389,920
20219958,485$1,694,659
20229649,402$1,532,564
20231,00819,752$1,564,041
202497528,489$1,565,930

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$204K$409K2015 Drug cost: $29,753 (USD; Tot_Drug_Cst)2016 Drug cost: $60,371 (USD; Tot_Drug_Cst)2017 Drug cost: $59,293 (USD; Tot_Drug_Cst)2018 Drug cost: $263,702 (USD; Tot_Drug_Cst)2019 Drug cost: $408,799 (USD; Tot_Drug_Cst)2020 Drug cost: $352,847 (USD; Tot_Drug_Cst)2021 Drug cost: $387,033 (USD; Tot_Drug_Cst)2022 Drug cost: $145,899 (USD; Tot_Drug_Cst)2023 Drug cost: $59,111 (USD; Tot_Drug_Cst)2024 Drug cost: $50,713 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015107218$29,753
2016102254$60,371
2017145328$59,293
2018178476$263,702
2019144445$408,799
2020121386$352,847
2021156473$387,033
2022173412$145,899
2023140345$59,111
2024145357$50,713

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system8191,105$98
67028Injection of drug into eye2421,074$93
92012Established patient problem focused exam of visual system266732$69
92134Imaging of retina8051,726$33
92250Photography of the retina120126$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium491,997$9,952
Prednisolone AcetatePrednisolone Acetate974,408$6,244
ProlensaBromfenac Sodium14556$6,123
MoxifloxacinMoxifloxacin Hcl65863$1,653
Brimonidine TartrateBrimonidine Tartrate13723$1,289

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$1,070Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.7$21,316Regeneron Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Raymond Wee, MD?

Tedicare shows public-source Medicare data for Raymond Wee, MD (NPI 1104980382), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Raymond Wee, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Raymond Wee, MD?

Raymond Wee, MD is linked to RETINA CONSULTANTS OF HAWAII INC (billing NPI 1124089446) in the available physician profile data.

Does Raymond Wee, MD have Open Payments data?

Raymond Wee, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.